West Pharmaceutical Services (WST) Revenue — Quarter Ended Jun 30, 2025
Revenue increased in the most recent quarter compared to both the preceding quarter and the same quarter one year earlier. The company reported higher net sales for the quarter and the first half of the year.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q2
Revenue increased in the most recent quarter compared to both the preceding quarter and the same quarter one year earlier. The company reported higher net sales for the quarter and the first half of the year.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$766.5M
Revenue reported for this quarter.
Quarter-over-quarter
+9.8%
Change from the immediately preceding quarter.
Year-over-year
+9.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $746.9M | -0.1% |
| Dec 31, 2024 | $748.8M | +2.3% |
| Mar 31, 2025 | $698M | +0.4% |
| Jun 30, 2025 | $766.5M | +9.2% |
Revenue performance
The quarter's revenue grew from the prior quarter, reversing a sequential decline seen in the previous period. It also exceeded the level of the same quarter last year.
Quarterly comparison
Compared with the immediately preceding quarter, revenue expanded. Versus the same quarter one year earlier, revenue also posted an increase.
What to watch
The sequential recovery following a prior quarter's decline may be a point to monitor for sustained momentum.